Medinotec Inc. MDNC
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.10% | 24.23% | -48.31% | -1.09% | 79.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.10% | 24.23% | -48.31% | -1.09% | 79.40% |
| Cost of Revenue | 30.94% | 10.03% | -18.08% | -21.87% | 29.10% |
| Gross Profit | -21.35% | 43.20% | -63.54% | 29.33% | 137.98% |
| SG&A Expenses | -4.90% | 89.49% | 185.17% | 82.98% | 266.99% |
| Depreciation & Amortization | 190.67% | 184.00% | 238.37% | -59.90% | -61.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.72% | 33.05% | 33.23% | -2.62% | 97.89% |
| Operating Income | -61.65% | -34.81% | -113.49% | 4.78% | 21.32% |
| Income Before Tax | -66.43% | -20.66% | -114.20% | 12.71% | 32.54% |
| Income Tax Expenses | -26.75% | -109.06% | -145.69% | -18.63% | 58.19% |
| Earnings from Continuing Operations | -88.20% | 95.08% | -104.69% | 30.00% | 21.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.20% | 95.08% | -104.69% | 30.00% | 21.74% |
| EBIT | -61.65% | -34.81% | -113.49% | 4.78% | 21.32% |
| EBITDA | -58.12% | -29.05% | -110.51% | 1.26% | 16.27% |
| EPS Basic | -88.14% | 94.85% | -105.99% | 0.00% | 47.50% |
| Normalized Basic EPS | -66.32% | -20.71% | -118.63% | -15.72% | 54.89% |
| EPS Diluted | -88.14% | 94.85% | -105.99% | 0.00% | 47.50% |
| Normalized Diluted EPS | -66.32% | -20.71% | -118.63% | -15.72% | 54.89% |
| Average Basic Shares Outstanding | 0.03% | 0.18% | -21.98% | 30.00% | -17.46% |
| Average Diluted Shares Outstanding | 0.03% | 0.18% | -21.98% | 30.00% | -17.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |